Kulothungan Gunasekaran
Critical Care Medicine · Yuma, AZNPI 1295171866
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 74.1% of it on its own, with 18 other manufacturers making up the rest. Among critical care medicine clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $90.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Actelion Pharmaceuticals US, Inc.$343
- Merck$250
- GSK$124
- AstraZeneca$99
- ANI Pharmaceuticals, Inc.$87
- plus $657 from 13 others
What the payments were for
- Travel & lodging$1,65928%
- Food & beverage$1,74529%
- Education$2,62644%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 17 | $4,471 |
| Actelion Pharmaceuticals US, Inc. | 6 | $343 |
| Merck | 2 | $250 |
| GSK | 7 | $124 |
| AstraZeneca | 5 | $99 |
| ANI Pharmaceuticals, Inc. | 3 | $87 |
| Boehringer Ingelheim | 3 | $87 |
| Verona Pharma, Inc. | 3 | $84 |
| Amgen | 4 | $82 |
| Sanofi | 3 | $75 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| Sanofi-aventis U.S. LLC | 1 | $57 |
| Electromed, Inc. | 4 | $39 |
| UCB, Inc. | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Edwards Lifesciences | 1 | $28 |
| Abiomed | 1 | $26 |
| Grifols USA, LLC | 1 | $24 |
| AbbVie | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,224
- WINREVAIR$250
- UPTRAVI$249
- OPSUMIT$249
How this compares
$6,031 in reported general payments places this provider in the 90th percentile of 175 critical care medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 143 | $109,665 |
| Pirfenidone | 24 | $95,950 |
| TezspireTezepelumab-Ekko | 16 | $64,038 |
| Spiriva RespimatTiotropium Bromide | 57 | $37,402 |
| Spiriva HandihalerTiotropium Bromide | 45 | $30,286 |
| Advair HfaFluticasone Propion/Salmeterol | 49 | $25,609 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 41 | $20,378 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $19,893 |
| Incruse ElliptaUmeclidinium Bromide | 48 | $19,159 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 23 | $15,348 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $13,225 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 20 | $12,178 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 279 | $9,741 |
| Pulmicort FlexhalerBudesonide | 24 | $6,989 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 29 | $5,804 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta, Breo Ellipta, Arnuity Ellipta | $124 | $168,032287 claims |
| AstraZenecaTezspire, Breztri Aerosphere, Pulmicort Flexhaler | $99 | $90,91966 claims |
| Boehringer IngelheimSpiriva Respimat, Combivent Respimat, Stiolto Respimat | $87 | $64,928100 claims |
| MerckDulera | $250 | $4,79011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 175 critical care medicine providers in Arizona.
Other critical care medicine in Yuma
- Naomi HabibPhoenix$298K
- Heather PrzybylPhoenix$126K
- Douglas MapelPrescott$125K
- Akshay MuralidharScottsdale$44K
- Syed ShahryarPhoenix$20K
- Rodrigo Cartin-CebaScottsdale$18K
- Robert MathenyKingman$10K
- Reena BansalScottsdale$10K
- Lina AnthonyMesa$6K
- Blythe DemelloTucson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.